Nursing Care: Altered Cellular Regulation in Pediatrics questions and answers rated A+

Nursing Care: Altered Cellular Regulation in Pediatricshe nurse is caring for a child with a Wilms tumor. Which assessment findings does the nurse anticipate? Select all that apply. - correct answer Children with Wilms tumors may present with an abdominal mass (most common finding), hematuria, and hypertension. Vomiting and unexplained bruising are not associated with Wilms tumors. The nurse is caring for a 5-year-old who will be undergoing surgery for removal of a neuroblastoma on the adrenal gland. Which are appropriate ways to help the child cope with their fear of the procedure? Select all that apply. - correct answer all Fill in the blank highest piority - correct answer Fluid and electrolyte imbalance, Ondansetron. The highest priority diagnosis for the nurse to address is fluid and electrolyte imbalance. The nurse should administer the client's prescribed ondansetron. Continued nausea and vomiting may result in imbalanced nutrition and acid-base imbalance, but these are secondary concerns to fluid and electrolyte imbalance. Child is N/V from chemo, what should the nurse do? - correct answer The nurse should allow the child to choose what to eat for meals, which addresses both the nutritional and developmental needs of the child. The nurse is caring for a toddler who is recovering from surgery to remove a cancerous tumor. Which assessment finding best indicates the child's pain is decreasing? - correct answer A child who is experiencing less pain will have more interest in normal toddler activities such as play. The nurse is caring for a client being treated for acute lymphocytic leukemia (ALL). The client's white blood cell count is 7,000 cells/mm³. A priority nursing diagnosis for this client is risk for infection. Which outcome best indicates the client remains infection-free? - correct answer Temp remains normal range The nurse is caring for a pediatric client who is undergoing chemotherapy treatment for acute lymphoblastic leukemia (ALL). The planned treatment is intermittent and may last up to two years.